Ocean Biomedical, Inc.
OCEA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001869974
No open-market purchases or sales by Ocean Biomedical, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Holders of 5% or more of OCEA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Ocean Biomedical, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Ayrton Capital LLC | 13G/A | 9.90%3.87M shares | – | Feb 13, 20251 filing | Feb 13, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
1 Schedule 13D or 13G filing on Ocean Biomedical, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 13, 20251:11 PM ET | Ayrton Capital LLCand 2 others | 13G/A | 9.90%3.87M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Ocean Biomedical, Inc. shares.
No Form 144 notices for Ocean Biomedical, Inc. are on file.